BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 19930596)

  • 1. Induction of granzyme B expression in T-cell receptor/CD28-stimulated human regulatory T cells is suppressed by inhibitors of the PI3K-mTOR pathway.
    Efimova OV; Kelley TW
    BMC Immunol; 2009 Nov; 10():59. PubMed ID: 19930596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
    Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
    Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granzyme B-expressing treg cells are enriched in colorectal cancer and present the potential to eliminate autologous T conventional cells.
    Sun B; Liu M; Cui M; Li T
    Immunol Lett; 2020 Jan; 217():7-14. PubMed ID: 31669380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged TCR/CD28 engagement drives IL-2-independent T cell clonal expansion through signaling mediated by the mammalian target of rapamycin.
    Colombetti S; Basso V; Mueller DL; Mondino A
    J Immunol; 2006 Mar; 176(5):2730-8. PubMed ID: 16493028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single CD28 stimulation induces stable and polyclonal expansion of human regulatory T cells.
    He X; Smeets RL; van Rijssen E; Boots AM; Joosten I; Koenen HJ
    Sci Rep; 2017 Feb; 7():43003. PubMed ID: 28223693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T cells.
    Valmori D; Tosello V; Souleimanian NE; Godefroy E; Scotto L; Wang Y; Ayyoub M
    J Immunol; 2006 Jul; 177(2):944-9. PubMed ID: 16818749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphatidylinositol 3-kinase inhibitors prevent mouse cytotoxic T-cell development in vitro.
    Phu T; Haeryfar SM; Musgrave BL; Hoskin DW
    J Leukoc Biol; 2001 May; 69(5):803-14. PubMed ID: 11358990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal granzyme/perforin-mediated death of human regulatory and responder T cells is regulated by interleukin-2 (IL-2).
    Czystowska M; Strauss L; Bergmann C; Szajnik M; Rabinowich H; Whiteside TL
    J Mol Med (Berl); 2010 Jun; 88(6):577-88. PubMed ID: 20225066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin.
    Strauss L; Czystowska M; Szajnik M; Mandapathil M; Whiteside TL
    PLoS One; 2009 Jun; 4(6):e5994. PubMed ID: 19543393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective expansion of memory CD4(+) T cells by mitogenic human CD28 generates inflammatory cytokines and regulatory T cells.
    Singh M; Basu S; Camell C; Couturier J; Nudelman RJ; Medina MA; Rodgers JR; Lewis DE
    Eur J Immunol; 2008 Jun; 38(6):1522-32. PubMed ID: 18446791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of inhibitors of the PI3K/mTOR pathway on the expansion and functionality of regulatory T cells.
    Huijts CM; Santegoets SJ; Quiles Del Rey M; de Haas RR; Verheul HM; de Gruijl TD; van der Vliet HJ
    Clin Immunol; 2016 Jul; 168():47-54. PubMed ID: 27189717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion.
    Turner MS; Kane LP; Morel PA
    J Immunol; 2009 Oct; 183(8):4895-903. PubMed ID: 19801514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutting Edge: Responder T cells regulate human DR+ effector regulatory T cell activity via granzyme B.
    Ashley CW; Baecher-Allan C
    J Immunol; 2009 Oct; 183(8):4843-7. PubMed ID: 19801510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs.
    Bocian K; Borysowski J; Wierzbicki P; Wyzgal J; Klosowska D; Bialoszewska A; Paczek L; Górski A; Korczak-Kowalska G
    Nephrol Dial Transplant; 2010 Mar; 25(3):710-7. PubMed ID: 19903662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells.
    Gallon L; Traitanon O; Yu Y; Shi B; Leventhal JR; Miller J; Mas V; L X; Mathew JM
    Transplantation; 2015 Sep; 99(9):1774-84. PubMed ID: 25905982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feedback loop of immune regulation by CD4+CD25+ Treg.
    Jung YJ; Seoh JY
    Immunobiology; 2009; 214(4):291-302. PubMed ID: 19327546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-Cell Sequencing Reveals the Transcriptome and TCR Characteristics of pTregs and
    Hui Z; Zhang J; Zheng Y; Yang L; Yu W; An Y; Wei F; Ren X
    Front Immunol; 2021; 12():619932. PubMed ID: 33868236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing the Effects of the mTOR Inhibitors Azithromycin and Rapamycin on In Vitro Expanded Regulatory T Cells.
    Bergström M; Müller M; Karlsson M; Scholz H; Vethe NT; Korsgren O
    Cell Transplant; 2019 Dec; 28(12):1603-1613. PubMed ID: 31512504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of calcineurin abrogates while inhibition of mTOR promotes regulatory T cell expansion and graft-versus-host disease protection by IL-2 in allogeneic bone marrow transplantation.
    Satake A; Schmidt AM; Nomura S; Kambayashi T
    PLoS One; 2014; 9(3):e92888. PubMed ID: 24658577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Autocrine TNFα-Tumor Necrosis Factor Receptor 2 Loop Promotes Epigenetic Effects Inducing Human Treg Stability
    Urbano PCM; Koenen HJPM; Joosten I; He X
    Front Immunol; 2018; 9():573. PubMed ID: 29619032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.